U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

APOE5 VARIANT

MedGen UID:
1381652
•Concept ID:
C4479660
•
Finding
OMIM®: 107741

Recent clinical studies

Diagnosis

Focal segmental glomerulosclerosis with heterozygous apolipoprotein E5 (Glu3Lys).
Sasaki M, Yasuno T, Ito K, Matsunaga A, Hisano S, Abe Y, Miyake K, Masutani K, Nakashima H, Saito T
CEN Case Rep 2018 Nov;7(2):225-228. Epub 2018 May 8 doi: 10.1007/s13730-018-0331-4. PMID: 29740794Free PMC Article

Therapy

Focal segmental glomerulosclerosis with heterozygous apolipoprotein E5 (Glu3Lys).
Sasaki M, Yasuno T, Ito K, Matsunaga A, Hisano S, Abe Y, Miyake K, Masutani K, Nakashima H, Saito T
CEN Case Rep 2018 Nov;7(2):225-228. Epub 2018 May 8 doi: 10.1007/s13730-018-0331-4. PMID: 29740794Free PMC Article

Clinical prediction guides

Apolipoprotein E5 (Glu212-->Lys): increased binding to cell surface proteoglycans but decreased uptake and lysosomal degradation in cultured fibroblasts.
Feussner G, Scharnagl H, Scherbaum C, Acar J, Dobmeyer J, Lohrmann J, Wieland H, März W
J Lipid Res 1996 Aug;37(8):1632-45. PMID: 8864947

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • ClinVar
      Related medical variations
    • OMIM
      Related records in OMIM
    • PubMed
      Related literature resources in PubMed
    • PubMed (OMIM)
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...